Timothy N. Estep

1.4k total citations
32 papers, 1.1k citations indexed

About

Timothy N. Estep is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Timothy N. Estep has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Cell Biology and 7 papers in Physiology. Recurrent topics in Timothy N. Estep's work include Hemoglobin structure and function (12 papers), Lipid Membrane Structure and Behavior (7 papers) and Protein purification and stability (5 papers). Timothy N. Estep is often cited by papers focused on Hemoglobin structure and function (12 papers), Lipid Membrane Structure and Behavior (7 papers) and Protein purification and stability (5 papers). Timothy N. Estep collaborates with scholars based in United States, Israel and France. Timothy N. Estep's co-authors include T. E. Thompson, Rodney L. Biltonen, Donald B. Mountcastle, Yechezkel Barenholz, Kenneth E. Burhop, G. Graham Shipley, Andranik Bagdasarian, Robert R. Wagner, Ranajit Pal and William A. Petri and has published in prestigious journals such as Blood, Biochemistry and Analytical Biochemistry.

In The Last Decade

Timothy N. Estep

30 papers receiving 994 citations

Peers

Timothy N. Estep
Waldo R. Fisher United States
Edwin G. Moore United States
D. Kamp Germany
Anita D. Wentworth United States
Timothy N. Estep
Citations per year, relative to Timothy N. Estep Timothy N. Estep (= 1×) peers F. Reibke Poulsen

Countries citing papers authored by Timothy N. Estep

Since Specialization
Citations

This map shows the geographic impact of Timothy N. Estep's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy N. Estep with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy N. Estep more than expected).

Fields of papers citing papers by Timothy N. Estep

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy N. Estep. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy N. Estep. The network helps show where Timothy N. Estep may publish in the future.

Co-authorship network of co-authors of Timothy N. Estep

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy N. Estep. A scholar is included among the top collaborators of Timothy N. Estep based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy N. Estep. Timothy N. Estep is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Estep, Timothy N.. (2025). Hemoglobin-based oxygen carriers, oxidative stress and myocardial infarction. Frontiers in Physiology. 16. 1551932–1551932.
2.
Estep, Timothy N.. (2019). Issues in the development of hemoglobin based oxygen carriers. Seminars in Hematology. 56(4). 257–261. 9 indexed citations
3.
Estep, Timothy N.. (2019). Haemoglobin-based oxygen carriers and myocardial infarction. Artificial Cells Nanomedicine and Biotechnology. 47(1). 593–601. 8 indexed citations
4.
Estep, Timothy N.. (2015). Pharmacokinetics and mechanisms of plasma removal of hemoglobin-based oxygen carriers. Artificial Cells Nanomedicine and Biotechnology. 43(3). 203–215. 7 indexed citations
5.
Kim, Hae Won & Timothy N. Estep. (2012). Practical Considerations in the Development of Hemoglobin-Based Oxygen Therapeutics. Current Drug Discovery Technologies. 9(3). 212–223. 2 indexed citations
6.
Estep, Timothy N., Enrico Bucci, John Harrington, et al.. (2008). Basic science focus on blood substitutes: a summary of the NHLBI Division of Blood Diseases and Resources Working Group Workshop, March 1, 2006. Transfusion. 48(4). 776–782. 31 indexed citations
7.
Burhop, Kenneth E., et al.. (2004). Review of Hemoglobin-Induced Myocardial Lesions. Artificial Cells Blood Substitutes and Biotechnology. 32(3). 353–374. 1 indexed citations
8.
Burhop, Kenneth E., et al.. (2004). Review of Hemoglobin-Induced Myocardial Lesions. Artificial Cells Blood Substitutes and Biotechnology. 32(3). 353–374. 55 indexed citations
9.
Burhop, Kenneth E., et al.. (2000). Evaluation and Validation of Virus Removal by Ultrafiltration During the Production of Diaspirin Crosslinked Haemoglobin (DCLHb). Biologicals. 28(2). 81–94. 8 indexed citations
10.
Baker, R., et al.. (1998). Validation of the Heat Treatment Step Used in the Production of Diaspirln Crosslinked Hemoglobin (DCLHb™) For Viral Inactivation. Artificial Cells Blood Substitutes and Biotechnology. 26(5-6). 577–582. 11 indexed citations
11.
Burhop, Kenneth E., Timothy N. Estep, Kurt L. Krause, et al.. (1997). Validation of the Heat Treatment Step Used in the Production of Diaspirin Crosslinked Hemoglobin (Delhb™) For Viral Deactivation - Effect of Crosslinking. Artificial Cells Blood Substitutes and Biotechnology. 25(6). 521–526. 8 indexed citations
12.
Estep, Timothy N., et al.. (1995). Resuscitation with Diaspirin Crosslinked Hemoglobin in a Pig Model of Hemorrhagic Shock. Artificial Cells Blood Substitutes and Biotechnology. 23(1). 39–61. 28 indexed citations
13.
Estep, Timothy N., et al.. (1992). Trace Element Analyses of Diaspirin Cross-Linked Hemoglobin Solutions. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 453–456. 6 indexed citations
14.
Estep, Timothy N., et al.. (1992). Immunogenicity of Diaspirin Cross-Linked Human Hemoglobin Solutions. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 603–609. 15 indexed citations
15.
Burhop, Kenneth E., et al.. (1992). Effects of Intravenous Infusions of Diaspirin Cross-Linked Hemoglobin (Dclhb) on Sheep. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 581–585. 21 indexed citations
16.
Nelson, Deanna J., Kenneth E. Burhop, Stephen Bush, et al.. (1992). Preparation and Characterization of Diaspirin Cross-Linked Hemoglobin Solutions for Preclinical Studies. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 423–427. 31 indexed citations
17.
Estep, Timothy N., et al.. (1988). Virus Inactivation in Hemoglobin Solutions by Heat. Biomaterials Artificial Cells and Artificial Organs. 16(1-3). 129–134. 39 indexed citations
18.
Bagdasarian, Andranik, et al.. (1988). Virus Removal or Inactivation in Hemoglobin Solutions by Ultrafiltration or Detergent/Solvent Treatment. Biomaterials Artificial Cells and Artificial Organs. 16(1-3). 123–128. 15 indexed citations
19.
Estep, Timothy N., et al.. (1984). Characterization of erythrocyte quality during the refrigerated storage of whole blood containing di-(2-ethylhexyl) phthalate. Blood. 64(6). 1270–1276. 68 indexed citations
20.
Estep, Timothy N., et al.. (1984). Characterization of erythrocyte quality during the refrigerated storage of whole blood containing di-(2-ethylhexyl) phthalate. Blood. 64(6). 1270–1276. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026